BUENAVENTURA COLLAZOS, D.; AGUILAR LONDOÑO, C.; ARISTIZÁBAL-HENAO, N.; TORRES-GRAJALES, J.; GUTIÉRREZ-RESTREPO, J. Lenvatinib dose-escalation therapy in a patient with papillary thyroid carcinoma after discontinuation due to a severe adverse event . Revista Colombiana de Endocrinología, Diabetes & Metabolismo, [S. l.], v. 12, n. 2, 2025. DOI: 10.53853/encr.12.2.934. Disponível em: https://revistaendocrino.org/index.php/rcedm/article/view/934. Acesso em: 14 may. 2026.